Reference number : 236-2018-2019-Q3-00589, amendment number : , agreement type : G, recipient legal name : Lavigne, Pierre, recipient country : CA, recipient province : QC, recipient city : Sherbrooke, recipient postal code : J1K 2R1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 868276.0, agreement start date : 2018-10-01, agreement end date : 2023-09-30, description english : Development of cancer therapies targeting Myc with cell penetrating b-HLH-LZ domains, description french : Development of cancer therapies targeting Myc with cell penetrating b-HLH-LZ domains, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada